Home

Headache

Alzheimer's Disease

Read time: 3 min

Congress highlights

Encouraging immune response to AD: adjuvants, modifying the microbiome, and microglial rejuvenation

Modulating central and peripheral innate immunity has potential in Alzheimer’s Disease....

Alzheimer's Disease

Read time: 4 min

Congress highlights

Making ready for early AD diagnosis

When disease-modifying therapy becomes available, screening for Alzheimer’s and its...

Read time: 1 min

World Mental Health Day 2019

Read time: 3 min

One size does not fit all…or does it?: Heterogeneity within depression

Depressive disorders are “the world’s most important cause of disability”, as...

Read time: 3 min

Positive steps to address negative symptoms in schizophrenia

A goal of precision psychiatry is to locate a patient along the continuum of the disease course,...

Read time: 2 min

Long-acting injectable or oral antipsychotic for first episode psychosis?

Antipsychotic therapy improves outcomes for patients with first episode of psychosis, yet a study...

Parkinson's Disease

Read time: 3 min

Congress highlights

What the brain teaches us about α-synuclein

In all affected brain regions, α-synuclein accumulates only in specific cell types, and only in...

Parkinson's Disease

Read time: 4 min

Congress highlights

Synucleinopathies see advances in biomarkers and imaging

Improved diagnostics and insights into pathogenesis were presented in the ADPD session that...

Alzheimer's Disease

Read time: 4 min

Congress highlights

What have we learned from Alzheimer’s trials?

Recent phase 3 trials in Alzheimer’s Disease teach us how to improve selection of patients so...

Parkinson's Disease

Read time: 4 min

A whirlwind tour of clinical trials of therapies addressing motor and non-motor symptoms in Parkinson’s disease

“There’s been lots of positive work looking at not only improving symptomatic...

Read time: 5 min

Strategies for reducing the duration of untreated psychosis

Longer duration of untreated psychosis (DUP) is related to poor clinical and functional outcomes in...

Read time: 2 min

Counting the indirect costs of psychosis

Early intervention (EI) services for people with psychosis are designed to improve outcomes,...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country